Pressroom: Media Coverage

Showing 521 - 540 of 656 news items


Boosting Defenses Against Cancer

Immunologist James Allison answered questions about the immunotherapy drug he developed, called ipilimumab (Yervoy™), approved by the FDA in March for patients with metastatic melanoma.

December 5, 2011
Lloyd J. Old, Champion of Using Cells to Fight Cancer, Dies at 78

Memorial Sloan Kettering’s Lloyd Old, internationally recognized as one of the founders and standard bearers of the field of tumor immunology, died on November 28. Immunologist and colleague James Allison commented on his passing in The Scientist.

December 5, 2011
Dogs with Cancer Helping to Find a Cure

Medical oncologist Jedd Wolchok talked about a drug he co-developed based on a therapeutic vaccine for dogs with melanoma.

December 2, 2011
Hormonal Prostate Cancer Therapy Tied to Blood Clots

Hormone-targeted therapy for prostate cancer may raise the risk of potentially dangerous blood clots, according to a new study published by Memorial Sloan Kettering researcher Behfar Ehdaie in the journal Cancer.

December 1, 2011
The Healthy Man

Chief of Memorial Sloan Kettering’s Rockville Centre’s Medical Oncology Service Kenneth Ng discussed what doctors want men to know about lung cancer.

December 1, 2011
Unexpected Complications: Treating Cancer during Pregnancy

Chief of Memorial Sloan Kettering’s Breast Cancer Medicine Service Clifford Hudis was quoted about the rarity of cancer in pregnancy and the difficulties associated with doing meaningful research in patients with cancer who are pregnant.

November 29, 2011
New Therapy Targets a Patient's Unique Cancer

Thoracic oncologist Mark Kris discussed molecular tumor typing and personalized medicine in the treatment of lung and other cancers.

November 23, 2011
Drug-Resistant Melanoma Finding May Improve Treatment Approach

Cancer researcher and member of the Human Oncology and Pathogenesis Program David Solit discussed a paper he published in Nature that identified a previously unknown mechanism of resistance to the newly approved melanoma drug vemurafenib. Dr. Solit was also quoted in the NCI Cancer Bulletin.

November 23, 2011
Should Medical School Be Free?

Epidemiologist Peter Bach talked about how making medical school free could send more young doctors into primary care and rural practice, thus solving one of the big challenges facing healthcare today.

November 21, 2011
Hospitals Increasingly Offer Complementary Medicine Treatments

Integrative Medicine Chief Barrie Cassileth responded to a survey finding that 42 percent of US hospitals offer at least one type of complementary medicine treatment. She warned that many herbal remedies create herb/drug interactions and emphasized the importance of offering evidence-based information about such interactions on Memorial Sloan Kettering’s About Herbs, Botanicals & Other Products database.

November 15, 2011
Brain Changes Seen in Breast-Cancer Survivors

Neuropsychologist James Root explained a common phenomenon called “chemo brain” or “chemo fog,” a phrase many cancer survivors use to describe losses in mental sharpness or altered mental function after cancer treatment.

November 15, 2011
A Conversation with Craig B. Thompson, MD

To mark the one-year anniversary of his tenure, President and CEO of Memorial Sloan Kettering Craig Thompson talked about recent discoveries and the challenges that remain in advancing better targeted treatments for difficult-to-treat cancers. Therapies pioneered at Memorial Sloan Kettering by Paul Chapman and James Allison, as well as research led by Renier Brentjens, were discussed.

November 15, 2011
Remembering Evelyn Lauder

Larry Norton, Medical Director of the Evelyn H. Lauder Breast Center, mourned the loss of Evelyn H. Lauder, a tireless cancer research advocate and a member of Memorial Sloan Kettering’s Board of Overseers.

November 12, 2011
Breast Reconstruction May Quickly Improve Quality of Life

Plastic surgeon Andrea Pusic used a questionnaire she developed, with support from the American Society of Plastic Surgeons, called the BREAST-Q, to assess patient satisfaction and quality of life after breast reconstruction. Results showed that women who underwent breast reconstruction after a mastectomy using their own abdominal tissue felt better about themselves as early as three weeks later.

November 11, 2011
Human Stem Cells Treat Parkinson’s in Mice

New research published in Nature by Sloan Kettering Institute developmental biologist Lorenz Studer describes how stem cells from human embryos were used to successfully treat Parkinson’s disease in mice and rats. “We see a real opportunity to develop this into an actual cell therapy for patients,” he told the Wall Street Journal.

November 7, 2011
Suicide Switch May Pave Way for Safer Cancer Treatment, Researchers Find

An editorial by Sloan Kettering Institute cell researcher Michel Sadelain responds to new research reported in the New England Journal of Medicine on a novel system to shut down cell therapies if their intended use goes awry. The approach could possibly help cut down on side effects from stem cell and other cell-based treatments. “The issue is that cells are complex living things and sometimes they do something we don’t want,” Sadelain told

November 3, 2011
Ovarian Cancer Research Previewed

Updates on ovarian cancer clinical trial results and findings on cause and treatment were presented by Memorial Sloan Kettering gynecologic pathologist Robert Soslow, gynecologist and geneticist Noah Kauff, gynecologic oncologist Paul Sabbatini, and others at the ‘Advances in Ovarian Cancer’ meeting in Dublin, Ireland.

November 3, 2011
ASCO Report: Accelerating Progress Against Cancer

Thoracic oncologist Mark Kris, who helped to co-author the American Society of Clinical Oncology (ASCO) plan for transforming clinical cancer research and speeding the creation of new therapies for patients, is cited in this story about a new road map for cancer treatment.

November 3, 2011
National Research Council Panel Calls for Google Maps of Human Disease

Charles Sawyers, co-chair of the National Research Council panel that has called for the creation of a massive data network that would combine cutting-edge genomic and molecular data on patients' diseases with their routine medical records, told Science Magazine and others at a briefing that while modest efforts like this already exist, "We want to do it on a bigger scale." Sawyers is Chair of Memorial Sloan Kettering's Human Oncology & Pathogenesis Program (HOPP).

November 2, 2011
Study Weakens Case for Preventive Mastectomy

Medical oncologist Mark Robson comments to the Wall Street Journal on findings published in the Journal of Clinical Oncology reporting that women with mothers and sisters who carry one of the BRCA gene mutations but who aren't carriers themselves don't have an especially heightened risk of breast cancer. Robson and medical oncologist Andrew Seidman were also quoted in MedPage Today, with Seidman expressing hope that the findings would cut down on "unwarranted and excessive screening and/or risk-reducing interventions."

November 1, 2011